PhRMA-Dynasty: How to Provide Antiretroviral Access to Developing Nations while Aligning Research Incentives for Pharmaceutical Companies in the Form of Profit and Intellectual Property Protection

DSpace/Manakin Repository

PhRMA-Dynasty: How to Provide Antiretroviral Access to Developing Nations while Aligning Research Incentives for Pharmaceutical Companies in the Form of Profit and Intellectual Property Protection

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Ornelas, Ariana en_US
dc.date.accessioned 2012-06-07T02:54:25Z
dc.date.issued 2006 en_US
dc.identifier.citation PhRMA-Dynasty: How to Provide Antiretroviral Access to Developing Nations while Aligning Research Incentives for Pharmaceutical Companies in the Form of Profit and Intellectual Property Protection (2006 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846752
dc.description.abstract The AIDS revolution has led to shockingly high rates of mortality in the developing world. Governments of developing and developed nations alike are on high alert, attempting to design appropriate strategies to combat the disease effectively. Within the international community, humanitarian organizations, NGO’s, and governments have all focused on the issue of treatment. However, treatment programs have reached an impasse due to trade agreements utilized to ensure respect for property rights, with the residual effect of increased pharmaceutical profit. The patent protection afforded to multinational pharmaceuticals by the TRIPS Agreement has served as an obstacle in improving access to life-sustaining medications and has posed a significant challenge to many global institutions and the states working on behalf of these institutions. Whether taking the approach of a human rights activist, an economist, the World Trade Organization, or a pharmaceutical researcher, the attainment of the highest possible standard of health must be the ultimate goal. en
dc.language.iso en_US en
dash.license META_ONLY en_US
dc.subject Food and Drug Law en
dc.subject AIDS en
dc.title PhRMA-Dynasty: How to Provide Antiretroviral Access to Developing Nations while Aligning Research Incentives for Pharmaceutical Companies in the Form of Profit and Intellectual Property Protection en
dc.type Paper (for course/seminar/workshop) en_US
dash.embargo.until 10000-01-01
dc.date.available 2012-06-07T02:54:25Z

Files in this item

Files Size Format View
Orneles06.pdf 243.0Kb PDF View/Open
Orneles06.rtf 180.5Kb RTF file View/Open
Orneles06.html 97.90Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters